Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
Useful markers from routine blood sampling as well as innovative soluble genetic markers.
»
12/03/20
Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detection
56 proteins were increased in serum samples from IDC patients.
»
12/02/20
Early macrophage infiltrates impair pancreatic cancer cell growth by TNF-α secretion
Only M0 macrophages harbor anti-tumorigenic activities and that M1, M2, and TAMs do not.
»
12/02/20
Rhenium N- heterocyclic carbene complexes block growth of aggressive cancers by inhibiting FGFR- and SRC-mediated signalling
Rhenium complex has anticancer activity in very aggressive cancers such as pancreatic ductal adenocarcinoma.
»
12/07/20
Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study
BPE associated with breast cancer in premenopausal women.
»
12/07/20
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk
Combined index based on MIPI together with RIS showed improved performance.
»
12/07/20
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
Pembrolizumab superior to chemotherapy with respect to progression-free survival.
»
12/02/20
Metformin use and lung cancer survival: a population-based study in Norway.
Dose-response relationship in all patients.
»
05/29/20
Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort.
Cohort supports use of olaparib as maintenance treatment.
»
05/28/20
Five-Year Survival in Patients with Nodular and Superficial Spreading Melanomas in the US Population.
Subgroup analyses showed inferior survival in NM in T1b.
»
03/29/20
< Prev
Next >